Fourth quarter revenue increased 14% to
$153 million
Fourth quarter net income of $15.3 million at a 10% margin; fourth quarter
adjusted EBITDA increased 29% to $61.4
million at a 40% margin
NEW
YORK, Feb. 28, 2025 /PRNewswire/ -- Integral Ad
Science (Nasdaq: IAS), a leading global media measurement and
optimization platform, today announced financial results for the
fourth quarter and full year ended December 31, 2024.
"We achieved 14% revenue growth in the fourth quarter with
double-digit gains across our optimization, measurement, and
publisher businesses," said Lisa
Utzschneider, CEO of IAS. "Throughout the year, we launched
several first-to-market solutions to increase advertiser returns
across the digital ecosystem. We look forward to driving value for
our customers in 2025 based on our AI-powered, differentiated
products, expanded platform partnerships, and global market
leadership."
Fourth Quarter 2024 Financial Highlights
- Total revenue was $153.0
million, a 14% increase compared to $134.3 million in the prior-year period.
- Optimization revenue was $70.6
million, an 11% increase compared to $63.6 million in the prior-year period.
- Measurement revenue was $59.1
million, a 12% increase compared to $52.6 million in the prior-year period.
- Publisher revenue was $23.4
million, a 30% increase compared to $18.1 million in the prior-year period.
- International revenue, excluding the Americas, was
$49.0 million, a 13% increase
compared to $43.3 million in the
prior-year period, or 32% of total revenue for the fourth quarter
of 2024.
- Gross profit was $119.7
million, a 13% increase compared to $106.0 million in the prior-year period. Gross
profit margin was 78% for the fourth quarter of 2024.
- Net income was $15.3
million, or $0.09 per basic
and diluted share, compared to $10.2
million, or $0.06 per basic
and diluted share, in the prior-year-period. Net income margin was
10% for the fourth quarter of 2024.
- Adjusted EBITDA* was $61.4
million, a 29% increase compared to $47.5 million in the prior-year period. Adjusted
EBITDA* margin was 40% for the fourth quarter of 2024.
Full Year 2024 Financial Highlights
- Total revenue was $530.1
million, a 12% increase compared to $474.4 million in the prior year.
- Optimization revenue was $242.6
million, an 8% increase compared to $224.5 million in the prior year.
- Measurement revenue was $211.0
million, a 13% increase compared to $186.0 million in the prior year.
- Publisher revenue was $76.5
million, a 20% increase compared to $63.8 million in the prior year.
- International revenue, excluding the Americas, was
$166.0 million, a 13% increase
compared to $146.8 million in the
prior year, or 31% of total revenue for the full year 2024.
- Gross profit was $416.1
million, an 11% increase compared to $375.0 million in the prior year. Gross profit
margin was 79% for the full year 2024.
- Net income was $37.8
million, or $0.23 per basic
and diluted share, compared to $7.2
million, or $0.04 per diluted
share, in the prior year. Net income margin was 7% for the full
year 2024.
- Adjusted EBITDA* was $191.3
million, a 20% increase compared to $159.5 million in the prior year. Adjusted
EBITDA* margin was 36% for the full year 2024.
- Cash and cash equivalents were $84.5 million at December
31, 2024.
Recent Business Highlights
- Meta Optimization Expansion – In February 2025, IAS announced new features and
increased global availability for its first-to-market Content Block
List optimization solution on Meta across Facebook and Instagram
Feed and Reels. IAS now supports 9 additional content categories
for a total of 45 and 6 additional languages for a total of
34.
- Brand Safety and Suitability on Reddit – In January 2025, Reddit announced that IAS is
integrated into Reddit's Limited inventory safety tier, and can now
provide advertisers with IAS's industry-leading, AI-driven
Multimedia Technology. Reddit also announced an integration with
IAS to measure the brand safety and brand suitability of
advertisers' campaigns on Reddit.
- Quality Sync Pre-Bid Integrations – In February 2025, IAS announced the integration of
Quality Sync pre-bid with Display and Video 360. In December 2024, IAS launched Quality Sync pre-bid
in Amazon DSP. Quality Sync seamlessly syncs advertisers' settings
to streamline their efforts and drive superior results.
- Quality Attention Expansion – In December 2024, IAS announced the release of its
new Quality Attention Optimization product and its first-to-market
partnership with Lumen Research to offer Social Attention. IAS now
provides advertisers complete coverage for attention metrics across
post-bid, pre-bid, and social media.
- China Expansion – In December
2024, IAS announced plans to expand into China to provide global advertisers with
invalid traffic, fraud, and brand safety and
suitability measurement, aligned to international and local
standards. IAS will also offer local support to Chinese advertisers
looking to grow their reach beyond China's borders.
- Kwai International Brand Safety Expansion – In
December 2024, IAS announced
exclusive first-to-market content-level brand safety and
suitability measurement for advertisers on Kwai for Business as
well as the launch of its Total Media Quality for Kwai product
suite.
- ISO Certification – In December
2024, IAS announced it has received an accredited ISO/IEC
42001 certification, making it the first measurement provider to
receive ISO certification for its use of AI, and one of the first
companies certified in the world.
Financial Outlook
Utzschneider commented, "In addition to 14% revenue growth in
the fourth quarter, we realized a 40% adjusted EBITDA margin for
the period. In 2025, we expect to deliver profitable, double-digit
revenue growth while maintaining a strong balance sheet and healthy
cash flows to fuel investment in the business."
IAS is introducing the following financial outlook for the first
quarter and full year 2025:
First Quarter Ending March 31,
2025:
- Total revenue of $128
million to $131 million
- Adjusted EBITDA* of $38
million to $40 million
Year Ending December 31,
2025:
- Total revenue of $588
million to $600 million
- Adjusted EBITDA* of $202
million to $210 million
* See "Supplemental Disclosure Regarding Non-GAAP Financial
Information" section herein for an explanation of Non-GAAP
measures. IAS is unable to provide a reconciliation for
forward-looking guidance of adjusted EBITDA to net income (loss),
the most closely comparable GAAP measure, because certain material
reconciling items, such as depreciation and amortization, interest
expense, income tax expense (benefit), restructuring and severance
costs, and acquisition and integration costs, cannot be estimated
due to factors outside of IAS's control and could have a material
impact on the reported results. However, IAS estimates stock-based
compensation expense for the first quarter of 2025 in the range of
$15 million to $17 million and for the full year 2025 in the
range of $77 million to $81 million. A reconciliation is not available
without unreasonable effort.
INTEGRAL AD SCIENCE HOLDING
CORP.
|
CONSOLIDATED BALANCE SHEETS
|
|
|
December 31,
|
(IN THOUSANDS, EXCEPT SHARE
DATA)
|
2024
|
|
2023
|
ASSETS
|
|
|
|
Current
assets:
|
|
|
|
Cash and cash
equivalents
|
$
84,469
|
|
$
124,759
|
Restricted
cash
|
506
|
|
54
|
Accounts receivable,
net of allowance for credit losses of $7,454 and $8,645 as of
December 31, 2024 and December 31, 2023, respectively
|
79,427
|
|
74,609
|
Unbilled
receivables
|
53,388
|
|
46,548
|
Prepaid expenses and
other current assets
|
36,639
|
|
18,959
|
Due from related
party
|
28
|
|
-
|
Total current
assets
|
254,457
|
|
264,929
|
Property and equipment,
net
|
4,004
|
|
3,769
|
Internal use software,
net
|
53,636
|
|
40,301
|
Intangible assets,
net
|
140,943
|
|
178,908
|
Goodwill
|
673,025
|
|
675,282
|
Operating lease
right-of-use assets, net
|
17,888
|
|
21,668
|
Deferred tax asset,
net
|
1,675
|
|
2,465
|
Other long-term
assets
|
5,943
|
|
4,402
|
Total
assets
|
$ 1,151,571
|
|
$ 1,191,724
|
LIABILITIES AND STOCKHOLDERS'
EQUITY
|
|
|
|
Current
liabilities:
|
|
|
|
Accounts payable and
accrued expenses
|
$
72,910
|
|
$
72,232
|
Operating lease
liabilities, current
|
10,184
|
|
9,435
|
Due to related
party
|
11
|
|
121
|
Deferred
revenue
|
1,061
|
|
682
|
Total current
liabilities
|
84,166
|
|
82,470
|
Deferred tax liability,
net
|
3,118
|
|
20,367
|
Long-term debt,
net
|
34,189
|
|
153,725
|
Operating lease
liabilities, non-current
|
13,374
|
|
19,523
|
Other long-term
liabilities
|
8,713
|
|
6,183
|
Total
liabilities
|
143,560
|
|
282,268
|
Commitments and
Contingencies (Note 15)
|
|
|
|
Stockholders'
Equity
|
|
|
|
Preferred Stock, $0.001
par value, 50,000,000 shares authorized at December 31, 2024; 0
shares issued and outstanding at December 31,
2024 and 2023
|
-
|
|
-
|
Common Stock, $0.001
par value, 500,000,000 shares authorized at December 31, 2024,
162,871,266 and 158,757,620 shares issued and
outstanding at December 31, 2024
and 2023, respectively
|
163
|
|
159
|
Additional
paid-in-capital
|
964,765
|
|
901,259
|
Accumulated other
comprehensive loss
|
(3,666)
|
|
(916)
|
Retained
earnings
|
46,749
|
|
8,954
|
Total stockholders'
equity
|
1,008,011
|
|
909,456
|
Total liabilities and
stockholders' equity
|
$ 1,151,571
|
|
$ 1,191,724
|
INTEGRAL AD SCIENCE HOLDING
CORP.
|
CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE INCOME
|
(UNAUDITED)
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
December 31,
|
|
Year ended
December 31,
|
(IN THOUSANDS, EXCEPT SHARE AND PER SHARE
DATA)
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Revenue
|
|
$
153,038
|
|
$
134,295
|
|
$
530,101
|
|
$
474,369
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
Cost of revenue
(excluding depreciation and
amortization shown below)
|
|
33,332
|
|
28,252
|
|
113,960
|
|
99,352
|
Sales and
marketing
|
|
30,753
|
|
30,423
|
|
122,294
|
|
117,989
|
Technology and
development
|
|
17,546
|
|
19,056
|
|
69,851
|
|
72,906
|
General and
administrative
|
|
24,310
|
|
25,961
|
|
95,717
|
|
111,634
|
Depreciation and
amortization
|
|
16,934
|
|
14,593
|
|
63,966
|
|
54,966
|
Foreign exchange loss
(gain), net
|
|
4,650
|
|
(501)
|
|
3,927
|
|
430
|
Total operating
expenses
|
|
127,525
|
|
117,784
|
|
469,715
|
|
457,277
|
Operating
income
|
|
25,513
|
|
16,511
|
|
60,386
|
|
17,092
|
Interest expense,
net
|
|
(571)
|
|
(2,489)
|
|
(5,358)
|
|
(12,236)
|
Net income before
income taxes
|
|
24,942
|
|
14,022
|
|
55,028
|
|
4,856
|
(Provision) benefit for
income taxes
|
|
(9,671)
|
|
(3,858)
|
|
(17,233)
|
|
2,382
|
Net income
|
|
$
15,271
|
|
$
10,164
|
|
$
37,795
|
|
$
7,238
|
Net income per
share:
|
|
|
|
|
|
|
|
|
Basic
|
|
$
0.09
|
|
$
0.06
|
|
$
0.23
|
|
$
0.05
|
Diluted
|
|
$
0.09
|
|
$
0.06
|
|
$
0.23
|
|
$
0.04
|
Weighted average shares
outstanding:
|
|
|
|
|
|
|
|
|
Basic
|
|
162,643,523
|
|
158,243,619
|
|
161,060,227
|
|
156,272,335
|
Diluted
|
|
166,541,025
|
|
163,060,805
|
|
165,465,836
|
|
161,723,131
|
Other comprehensive
income:
|
|
|
|
|
|
|
|
|
Foreign currency
translation adjustments
|
|
(2,390)
|
|
2,772
|
|
(2,750)
|
|
1,983
|
Total comprehensive
income
|
|
$
12,881
|
|
$
12,936
|
|
$
35,045
|
|
$
9,221
|
INTEGRAL AD SCIENCE HOLDING
CORP.
|
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS'
EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock
|
|
|
|
|
|
|
|
|
(IN THOUSANDS, EXCEPT SHARES
DATA)
|
|
Shares
|
|
Amount
|
|
Additional
paid-in
capital
|
|
Accumulated
other
comprehensive
loss
|
|
Retained
earnings
(accumulated
deficit)
|
|
Total
stockholders'
equity
|
Balance at December 31, 2021
|
|
154,398,495
|
|
$
154
|
|
$
781,951
|
|
$
(315)
|
|
$
(14,600)
|
|
$
767,190
|
RSUs vested
|
|
1,084,966
|
|
1
|
|
-
|
|
-
|
|
-
|
|
1
|
Option
exercises
|
|
1,586,728
|
|
2
|
|
7,153
|
|
-
|
|
-
|
|
7,155
|
Stock-based
compensation
|
|
-
|
|
-
|
|
44,733
|
|
-
|
|
-
|
|
44,733
|
Foreign currency
translation adjustment
|
|
-
|
|
-
|
|
-
|
|
(2,584)
|
|
-
|
|
(2,584)
|
Repurchase of common
stock
|
|
(3,080,061)
|
|
(3)
|
|
(23,652)
|
|
-
|
|
-
|
|
(23,655)
|
Net income
|
|
-
|
|
-
|
|
-
|
|
-
|
|
15,373
|
|
15,373
|
Balance at December 31, 2022
|
|
153,990,128
|
|
$
154
|
|
$
810,186
|
|
$
(2,899)
|
|
$
775
|
|
$
808,216
|
RSUs and MSUs
vested
|
|
3,492,130
|
|
4
|
|
-
|
|
-
|
|
-
|
|
4
|
Option
exercises
|
|
1,001,793
|
|
1
|
|
7,988
|
|
-
|
|
-
|
|
7,989
|
ESPP
purchase
|
|
273,569
|
|
-
|
|
2,306
|
|
-
|
|
-
|
|
2,306
|
Stock-based
compensation
|
|
-
|
|
-
|
|
80,779
|
|
-
|
|
-
|
|
80,779
|
Foreign currency
translation adjustment
|
|
-
|
|
-
|
|
-
|
|
1,983
|
|
-
|
|
1,983
|
Adoption of ASC 326,
net of tax
|
|
-
|
|
-
|
|
-
|
|
-
|
|
941
|
|
941
|
Net income
|
|
-
|
|
-
|
|
-
|
|
-
|
|
7,238
|
|
7,238
|
Balance at December 31, 2023
|
|
158,757,620
|
|
$
159
|
|
$
901,259
|
|
$
(916)
|
|
$
8,954
|
|
$
909,456
|
RSUs and MSUs
vested
|
|
3,723,743
|
|
4
|
|
-
|
|
-
|
|
-
|
|
4
|
Option
exercises
|
|
64,049
|
|
-
|
|
409
|
|
-
|
|
-
|
|
409
|
ESPP
purchase
|
|
325,854
|
|
-
|
|
3,373
|
|
-
|
|
-
|
|
3,373
|
Stock-based
compensation
|
|
-
|
|
-
|
|
59,724
|
|
-
|
|
-
|
|
59,724
|
Foreign currency
translation adjustment
|
|
-
|
|
-
|
|
-
|
|
(2,750)
|
|
-
|
|
(2,750)
|
Net income
|
|
-
|
|
-
|
|
-
|
|
-
|
|
37,795
|
|
37,795
|
Balance at December 31, 2024
|
|
162,871,266
|
|
$
163
|
|
$
964,765
|
|
$
(3,666)
|
|
$
46,749
|
|
$ 1,008,011
|
INTEGRAL AD SCIENCE HOLDING
CORP.
|
CONSOLIDATED STATEMENTS OF CASH
FLOWS
|
|
|
|
|
|
|
|
|
Year ended December 31,
|
(IN THOUSANDS)
|
|
2024
|
|
2023
|
Cash flows from operating
activities:
|
|
|
|
|
Net income
|
|
$
37,795
|
|
$
7,238
|
Adjustments to
reconcile net income to net cash provided by operating
activities:
|
|
|
|
|
Depreciation and
amortization
|
|
63,966
|
|
54,966
|
Stock-based
compensation
|
|
59,762
|
|
81,103
|
Foreign currency loss
(gain), net
|
|
2,898
|
|
(484)
|
Deferred tax
benefit
|
|
(16,417)
|
|
(21,531)
|
Amortization of debt
issuance costs
|
|
464
|
|
463
|
Allowance for credit
losses
|
|
21
|
|
3,816
|
Impairment of
assets
|
|
170
|
|
33
|
Changes in operating
assets and liabilities:
|
|
|
|
|
Increase in accounts
receivable
|
|
(6,223)
|
|
(8,148)
|
Increase in unbilled
receivables
|
|
(7,369)
|
|
(4,685)
|
(Increase) decrease in
prepaid expenses and other current assets
|
|
(18,722)
|
|
6,418
|
Increase in operating
leases, net
|
|
(1,561)
|
|
(29)
|
(Increase) decrease in
other long-term assets
|
|
(1,785)
|
|
375
|
Increase in accounts
payable and accrued expenses and other
long-term liabilities
|
|
4,654
|
|
11,478
|
Increase in deferred
revenue
|
|
383
|
|
582
|
(Decrease) increase in
due to/from related party
|
|
(138)
|
|
28
|
Net cash provided by
operating activities
|
|
117,898
|
|
131,623
|
Cash flows from investing
activities:
|
|
|
|
|
Payment for
acquisitions, net of acquired cash
|
|
-
|
|
(966)
|
Purchase of property
and equipment
|
|
(1,784)
|
|
(1,975)
|
Acquisition and
development of internal use software and other
|
|
(38,760)
|
|
(31,777)
|
Net cash used in
investing activities
|
|
(40,544)
|
|
(34,718)
|
Cash flows from financing
activities:
|
|
|
|
|
Repayment of long-term
debt
|
|
(120,000)
|
|
(145,000)
|
Proceeds from the
Revolver
|
|
-
|
|
75,000
|
Proceeds from exercise
of stock options
|
|
409
|
|
7,989
|
Cash received from
Employee Stock Purchase Program (ESPP)
|
|
3,213
|
|
3,160
|
Net cash used in
financing activities
|
|
(116,378)
|
|
(58,851)
|
Net (decrease) increase
in cash, cash equivalents, and restricted cash
|
|
(39,024)
|
|
38,054
|
Effect of exchange rate
changes on cash, cash equivalents, and restricted cash
|
|
(931)
|
|
(435)
|
Cash, cash equivalents,
and restricted cash, at beginning of year
|
|
127,290
|
|
89,671
|
Cash, cash equivalents, and restricted cash, at end
of year
|
|
$
87,335
|
|
$
127,290
|
Supplemental Disclosures:
|
|
|
|
|
Net cash paid during
the year for:
|
|
|
|
|
Interest
|
|
$
4,901
|
|
$
11,229
|
Taxes
|
|
$
34,800
|
|
$
10,985
|
Non-cash investing and
financing activities:
|
|
|
|
|
Property and equipment
acquired included in accounts payable
|
|
$
324
|
|
$
431
|
Internal use software
acquired included in accounts payable
|
|
$
816
|
|
$
1,444
|
Lease liabilities
arising from right-of-use assets
|
|
$
6,030
|
|
$
6,282
|
Supplemental Disclosure Regarding Non-GAAP Financial
Information
We use supplemental measures of our performance, which are
derived from our consolidated financial information, but which are
not presented in our consolidated financial statements prepared in
accordance with GAAP. Adjusted EBITDA is the primary financial
performance measure used by management to evaluate our business and
monitor ongoing results of operations. Adjusted EBITDA is defined
as income/loss before depreciation and amortization, stock-based
compensation, interest expense, income taxes, restructuring and
severance costs, acquisition and integration costs, foreign
exchange gains and losses, and other one-time, non-recurring costs.
Adjusted EBITDA margin represents the adjusted EBITDA for the
applicable period divided by the revenue for that period presented
in accordance with GAAP.
We use non-GAAP financial measures to supplement financial
information presented on a GAAP basis. We believe that excluding
certain items from our GAAP results allows management to better
understand our consolidated financial performance from period to
period and better project our future consolidated financial
performance as forecasts are developed at a level of detail
different from that used to prepare GAAP-based financial measures.
Moreover, we believe these non-GAAP financial measures provide our
shareholders with useful information to help them evaluate our
operating results by facilitating an enhanced understanding of our
operating performance and enabling them to make more meaningful
period-to-period comparisons. Although we believe these measures
are useful to investors and analysts for the same reasons they are
useful to management, these measures are not a substitute for, or
superior to, U.S. GAAP financial measures or disclosures. Our
non-GAAP financial measures may not be comparable to similarly
titled measures of other companies. Other companies, including
companies in our industry, may calculate non-GAAP financial
measures differently than we do, limiting the usefulness of those
measures for comparative purposes.
Reconciliation of historical adjusted EBITDA and corresponding
margin to their most directly comparable GAAP financial measures,
net income/loss and corresponding margin are presented below. We
encourage you to review the reconciliations in conjunction with the
presentation of the non-GAAP financial measures for each of the
periods presented. In future fiscal periods, we may exclude such
items and may incur income and expenses similar to these excluded
items.
Reconciliation of Adjusted
EBITDA
|
|
|
|
|
|
|
|
|
|
(IN THOUSANDS, EXCEPT
PERCENTAGES)
|
|
Three months ended
December 31,
|
|
Year ended
December 31,
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net income
|
|
$
15,271
|
|
$
10,164
|
|
$
37,795
|
|
$
7,238
|
Depreciation and
amortization
|
|
16,934
|
|
14,593
|
|
63,966
|
|
54,966
|
Stock-based
compensation
|
|
12,577
|
|
15,462
|
|
59,762
|
|
81,103
|
Interest expense,
net
|
|
571
|
|
2,489
|
|
5,358
|
|
12,236
|
Provision (benefit) for
income taxes
|
|
9,671
|
|
3,858
|
|
17,233
|
|
(2,382)
|
Acquisition,
restructuring and integration costs
|
|
1,543
|
|
1,054
|
|
3,008
|
|
4,028
|
Foreign exchange loss
(gain), net
|
|
4,650
|
|
(501)
|
|
3,927
|
|
430
|
Asset impairments and
other costs
|
|
133
|
|
396
|
|
223
|
|
1,913
|
Adjusted
EBITDA
|
|
$
61,350
|
|
$
47,515
|
|
$
191,272
|
|
$
159,532
|
Revenue
|
|
$
153,038
|
|
$
134,295
|
|
$
530,101
|
|
$
474,369
|
Net income
margin
|
|
10 %
|
|
8 %
|
|
7 %
|
|
2 %
|
Adjusted EBITDA
margin
|
|
40 %
|
|
35 %
|
|
36 %
|
|
34 %
|
Stock-Based Compensation
|
|
|
|
|
|
|
|
|
|
Three months ended
December 31,
|
|
Year ended
December 31,
|
(IN THOUSANDS)
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Cost of
revenue
|
$
82
|
|
$
124
|
|
$
368
|
|
$
452
|
Sales and
marketing
|
3,780
|
|
5,512
|
|
17,782
|
|
23,371
|
Technology and
development
|
5,059
|
|
4,104
|
|
19,198
|
|
17,538
|
General and
administrative
|
3,656
|
|
5,722
|
|
22,414
|
|
39,742
|
Total stock-based compensation
|
$
12,577
|
|
$
15,462
|
|
$
59,762
|
|
$
81,103
|
Conference Call and Webcast Information
IAS will host
a conference call and live webcast to discuss its fourth quarter
and full year 2024 financial results today at 8:30 a.m. ET. To access the live webcast and
conference call dial-in, please register under the "News &
Events" section of IAS's investor relations website. A replay will
be available on IAS's investor relations website following the live
call: https://investors.integralads.com.
About Integral Ad Science
Integral Ad Science (IAS) is
a leading global media measurement and optimization platform that
delivers the industry's most actionable data to drive superior
results for the world's largest advertisers, publishers, and media
platforms. IAS's software provides comprehensive and enriched data
that ensures ads are seen by real people in safe and suitable
environments while improving return on ad spend for advertisers and
yield for publishers. Our mission is to be the global benchmark for
trust and transparency in digital media quality. For more
information, visit integralads.com.
Forward-Looking Statements
This earnings press release
contains forward-looking statements that are subject to risks and
uncertainties. All statements other than statements of historical
fact included in this press release are forward-looking statements.
Forward-looking statements give our current expectations and
projections relating to our financial condition, results of
operations, plans, objectives, future performance and business. You
can identify forward-looking statements by the fact that they do
not relate strictly to historical or current facts. These
statements may include words such as "anticipate," "estimate,"
"expect," "project," "plan," "intend," "believe," "may," "will,"
"should," "can have," "likely," and other words and terms of
similar meaning in connection with any discussion of the timing or
nature of future operating or financial performance or other
events. For example, all statements we make relating to our
estimated and projected costs, expenditures, cash flows, growth
rates and financial results or our plans and objectives for future
operations, growth initiatives, strategies, client wins, or market
penetration are forward-looking statements. All forward-looking
statements are subject to risks and uncertainties that may cause
actual results to differ materially from those that we expected,
including: (i) factors that affect the amount of advertising
spending, such as economic downturns, instability in geopolitical
or market conditions, and changes in tax treatment of advertising
expenses; (ii) our failure to innovate or make the right investment
decisions; (iii) our ability to provide digital or cross-platform
analytics; (iv) our ability to sustain our profitability and
revenue growth rate, particularly if our revenue growth continues
to decline; (v) issues with the development and use of artificial
intelligence and machine learning; (vi) our failure to maintain or
achieve industry accreditation standards; (vii) our dependence on
integrations with advertising platforms, demand side providers
("DSPs"), proprietary platforms, and ad servers that we do not
control; (viii) our ability to maintain high impression volumes;
(ix) our ability to compete successfully with our current or future
competitors in an intensely competitive market; (x) our
international expansion; (xi) our ability to expand into new
channels; (xii) risks that our customers do not pay or choose to
dispute their invoices; (xiii) risks of material changes to revenue
share agreements with certain DSPs; (xiv) our dependence on the
overall demand for advertising; (xv) our ability to effectively
manage our growth; (xvi) the impact that any acquisitions we have
completed in the past and may consummate in the future, strategic
investments, or alliances may have on our business, financial
condition, and results of operations; (xvii) our ability to
successfully execute our international plans; (xviii) the risks
associated with the seasonality of our market; (xix) the difficulty
in evaluating our future prospects given our short operating
history; (xx) uncertainty in how the market for buying digital
advertising verification solutions will evolve; (xxi) interruption
by man-made problems such as terrorism, computer viruses, or social
disruptions; (xxii) the risk of failures in the systems and
infrastructure supporting our solutions and operations; (xxiii) our
ability to avoid operational, technical, and performance issues
with our platform; (xxiv) risks associated with any unauthorized
access to user, customer, or inventory and third-party provider
data; (xxv) our ability to provide the non-proprietary technology,
software, products, and services that we use; (xxvi) the risk that
we are sued by third parties for alleged infringement,
misappropriation, or other violation of their proprietary rights;
(xxvii) our ability to obtain, maintain, protect, or enforce
intellectual property and proprietary rights that are important to
our business; (xxviii) our involvement in lawsuits to protect or
enforce our intellectual property; (xxix) risks that our employees,
consultants, or advisors have wrongfully used or disclosed
alleged trade secrets of their current or former
employers; (xxx) risks that our trademarks and trade names are not
adequately protected; (xxxi) the impact of unforeseen changes to
privacy and data protection laws and regulation on digital
advertising; (xxxii) our ability to maintain our corporate culture;
(xxxiii) risks posed by earthquakes, fires, floods, public health
crises, and other natural catastrophic events; (xxxiv) the risk
that a perceived failure to comply with laws and industry
self-regulation may damage our reputation; and (xxxv) other factors
disclosed in our filings with the SEC. Given these factors, as well
as other variables that may affect our operating results, you
should not rely on forward-looking statements, assume that past
financial performance will be a reliable indicator of future
performance, or use historical trends to anticipate results or
trends in future periods.
We derive many of our forward-looking statements from our
operating budgets and forecasts, which are based on many detailed
assumptions. While we believe that our assumptions are reasonable,
we caution that it is very difficult to predict the impact of known
factors, and it is impossible for us to anticipate all factors that
could affect our actual results. The forward-looking statements
included in this press release are made only as of the date hereof.
We undertake no obligation to update or revise any forward- looking
statement as a result of new information, future events or
otherwise, except as otherwise required by law.
Investor Contact:
Jonathan
Schaffer
ir@integralads.com
Media Contact:
press@integralads.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ias-reports-fourth-quarter-and-full-year-2024-financial-results-302388116.html
SOURCE Integral Ad Science, Inc.